Abstract
In patients with advanced head and neck squamous cell carcinoma (HNSC), evidence of cell-mediated immunity and monocyte functional abnormalities has been reported. We studied the production of interleukin 1 beta (IL-1 beta) and interleukin 6 (IL-6) by peripheral blood monocytes from 22 patients with HNSC (12 larynx and ten oral cavity cancers) in comparison with monocyte cytokine production of age-matched healthy subjects. Pure monocytes were incubated with and without lipopolysaccharides (LPS) (10 micrograms ml-1) for 4 h at 37 degrees C and IL-1 beta and IL-6 concentrations were determined in supernatants by specific ELISA. There was no significant difference in IL-1 beta levels in monocyte supernatants from cancer in comparison to control subjects; conversely, a higher IL-6 production by unstimulated and LPS-activated cells from HNSC patients than from controls was found. No relationship was observed between cytokine production and cancer stage. The regression analysis evidenced a significant correlation between IL-1 beta and IL-6 monocyte-release in HNSC patients and in controls, so suggesting a possible autocrine control of IL-6 production by other cytokines.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gallo, O., Gori, A., Attanasio, M. et al. Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer. Br J Cancer 68, 465–468 (1993). https://doi.org/10.1038/bjc.1993.371
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.371
- Springer Nature Limited
This article is cited by
-
Mononuclear phagocytes in head and neck squamous cell carcinoma
European Archives of Oto-Rhino-Laryngology (2010)
-
Serum Levels of IL-lβ, IL-6, TNF-α, sTNF-RI and CRP in Patients with oral cavity cancer
Pathology & Oncology Research (1997)